Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood

Minerva Gastroenterologica e Dietologica

Volumn 55, Issue 1, 2009, Pages 53-70

  Maggiore, G ^a,c   Riva, S ^b   Sciveres, M ^b  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

^c S Chiara Hospital   (Italy)

Author keywords

Autoimmune diseases; Biliary tract diseases; Child; Liver diseases

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; LIVER CYTOSOL ANTIBODY 1; LIVER KIDNEY MICROSOME ANTIBODY 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; SMOOTH MUSCLE ANTIBODY; STEROID; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ANTIBODY TITER; AUTOIMMUNE HEPATITIS; CATARACT; CHRONIC LIVER DISEASE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CYTOPENIA; DIARRHEA; DISEASE ASSOCIATION; DIZZINESS; DRUG EFFICACY; ENTERITIS; GENETIC SUSCEPTIBILITY; GROWTH DISORDER; HAIR LOSS; HEADACHE; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INCREASED APPETITE; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MONOTHERAPY; NEUTROPENIA; NONHUMAN; OBESITY; PATHOGENESIS; PRIMARY SCLEROSING CHOLANGITIS; PROGNOSIS; REVIEW; SEX DIFFERENCE; SIDE EFFECT; SKIN DISEASE; TREATMENT WITHDRAWAL; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHILD; CHOLANGITIS, SCLEROSING; HEPATITIS, AUTOIMMUNE; HUMANS; SYNDROME;

EID: 67649410704     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Mieli Vergani G, Vergani D. Autoimmune paediatric liver disease. World J Gastroenterol 2008;14:3360-7.
2. Dahlan Y, Smith L, Simmonds D, Douglas L, Jewell LD, Wanless I et al. Pediatric-onset primary biliary cirrhosis. Gastroenterology 2003;125:1476-9.
3. Waldenstrom J. Leber blutproteine und Nahrungsei-weisse. Dtsch Gesellsch Verd Stoffw 195O;15:113-9.
4. Mackay IR, Taft LI, Cowling DC. Lupoid hepatitis. Lancet 1956;2:1323-6.
5. Odievre M, Maggiore G, Homberg JC, Saadoun F, Courouce AM, Yvart J et al. Seroimmunologic classification of chronic hepatitis in 57children. Hepatology 1983; 3: 407-9
6. Johnson PJ, McFarlane IG. Meeting Report. International Autoimmune Hepatitis Group". Hepatology 1993; 18:998-1005.
7. Boberg KM. Prevalence and epidemiology of autoimmune hepatitis. Clin Liver Dis 2002;6:347-59.
8. Alvarez F. Autoimmune hepatitis and primary scleros-ing cholangitis. Clin Liv Dis 2006;10:89-107.
9. Gregorio GV, Portmann B, Reid F, Donaldson PT Doherty DG, McCartney M et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997;25:54l-7.
10. Maggiore G, Veber F, Bernard O, Hadchouel M. Homberg JC, Alvarez F. Autoimmune hepatitis associated with anti-actin antibodies in children. J Pediatr Gastroenterol Nutr 1993;17:376-81.
11. Maggiore G, Bernard O, Homberg JC, Hadchouel M, Alvarez F, Hadchouel P et al. Liver disease associated with anti-liver-kidney microsome antibody in children. J Pediatr 1986;108:399-401.
12. Bridoux-Henno L, Maggiore G, Johanet C, Fabre M, Vajro P, Dommergues JP etal. Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody. Clin Gastroenterol Hepatol 2004;2:825-30.
13. Maggiore G, Porta G, Bernard O, Hadchouel M, Alvarez F, Homberg JC etal. Autoimmune hepatitis with initial presentation as acute hepatic failure in young children. J Pediatr 1990;ll6:280-2.
14. Caprai S, Vajro P, Ventura A, Sciveres M, Maggiore G. Autoimmune Liver disease associated with celiac disease in childhood: a multicenter study. Clin Gastroenterol Hepatol 2008;6:803-6.
15. Vogel A, Liermann H, Harms A, Strassburg CP, Manns MP, Obermayer-Straub P. Autoimmune regulator AIRE: evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1. Hepatology 2001; 33:1047-52.
16. Guegen M, Meunier-Rotival M, Bernard O. Alvarez F. Anti-liver kidney microsome antibody recognize a cytochrome P45O from the IID subfamily. J Exp Med 1988; 168: 801-6.
17. Cemente MG, Meloni A, Obermayer-Straub P, Frau F, Manns MP, De Virgiliis S. Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1. Gastroenterology 1998: 114:324-8.
18. Muratori L, Parola M, Ripalti A, Robino G, Muratori P. Bellomo G et al. Liver/kidney microsomial antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut 2000;46:553-6l.
19. Lapierre P, Djilali-Saiah I, Vitozzi S, Alvarez F. A murine model of type 2 autoimmune hepatitis: xenoimmu-nization with human antigens. Hepatology 2004;39: 1066-74.
20. Martini E, Abuaf N, Cavalli F, Durand V. Johanet C, Homberg JC Antibody to liver cytosol (anti-LCI) in patients with autoimmune chronic active hepatitis type 2. Hepatology 1988;8:1662-6.
21. Lapierre P, Hajoui O, Homberg JC, Alvarez F. Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. Gastroenterology 1999;116:643-9.
22. Vergani D, Mieli Vergani G. The impact of autoimmu-nity on hepatocytes. Sem Liv Dis 2007:2:140-51.
23. Czaja AJ, Donaldson PT. Genetic susceptibility for immune expression and liver cell injury in autoimmune hepatitis. Immunol Rev 2000;174:250-9.
24. Lankisch TO, Strassburg CP, Debray D, Manns MP, Jacquemin E. Detection of autoimmune regulator gene mutations in children with type 2 autoimmune hepatitis and extrahepatic immune mediated diseases. J Pediatr 2005;146:839-42.
25. Lohr H, Treichel U, Poralla T Manns M, Meyer Zum Buschenfelde KH. Liver infiltrating T-helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialo-glycoprotein receptor in vitro. Clin Exp Immunol 1992;88:45-9.
26. Muratori L, Parola M, Ripalti A. Robino G, Muratori P. Bellomo G et al. Liver/kidney microsomial antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut 2000;46:553-61.
27. Vento S, HegartyJE, Bottazzo G, Macchia E, Williams R, Eddleston AL et al. Antigen specific suppressor cell function in autoimmune chronic active hepatitis. Lancet 1984;l:1200-4.
28. Longhi MS. Ma Y, Bogdanos DP. Cheeseman P, Mieli-Vergani G, Vergani D et al. Impairment of CD4+CD25+ regulatory T -cells in autoimmune liver disease. 1 Hepatol 2004;41:31-7.
29. Lapierre P, Djilali-Saiah I, Vitozzi S. Alvarez F. A murine model of type 2 autoimmune hepatitis: xenoimmu-nization with human antigens. Hepatology 2004;39: 1066-74.
30. Alvarez F, Berg PA, Bianchi FB. Bianchi L. Burroughs AK, Cancado EL et al. International Autoimmune hepatitis Group report. Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999:31:929-38.
31. Ebbeson RL, Schreiber RA. Diagnosing Autoimmune hepatitis in children: is the International Autoimmune Hepatitis Group Scoring System useful? Clin Gastro Hepatol 2004;2:935-40.
32. Hennes EM, Zeniya M, Czaja A. Pares A. Dalekos GN. Krawitt EL et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008:48:169-76.
33. Maggiore G, Bernard O, Hadchouel M. Hadchouel P. Odievre M, Alagille D. Treatment of autoimmune chronic active hepatitis in childhood. J Pediatr 1984:104: 839-44.
34. Johnson PJ, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimm-mune hepatitis. N EnglJ Med 1995:333:958-63.
35. Sciveres M, Caprai S, Palla G, Ughi C. Maggiore G. Effectiveness and safety of ciclosporin as therapy for autoimmune diseases of the liver in children and adolescents Aliment Pharmacol Ther 2004;19:209-17.
36. Feldstein AE, Perrault J, El-Youssif M, Lindor K, Freese D, Angulo P. Primary sclerosing cholangitis in children: a long term follow-up study. Hepatology 2003;38:210-7.
37. Loftus EV Jr, Harewood GC, Loftus CG . Tremaine W'J, Harmsen WS. Zinsmeister A et al. PSC-1BD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 2005;54:91-6.
38. Chapman RW. Small duct primary sclerosing cholangitis. J Hepatol 2002;36:692-4.
39. Invernizzi P, Mackay IR. Overlap syndromes among autoimmune liver diseases. World J Gastroenterol 2008;l4:3368-73.
40. Abdo AA, Bain VG, Kichian K. Lee SS. Evolution of autoimmune hepatitis to primary sclerosing cholangitis: A sequential syndrome. Hepatology 2002:36: 1393-9.
41. Gregorio GV, Portmann B. Karani J. Harrison P. Donaldson PT, Vergani D et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 2OOl;33:544-53.
42. Al Chalabi T, Portmann B C. Bernal W. McFarlane IG. Heneghan MA. Autoimmune hepatitis overlap syndromes: evaluation of treatment response, long term outcome and survival. Aliment Pharmacol Ther 2008;28:209-20.
43. Floreani A, Rizzotto E R. Ferrara F. Carderi I. Caroli D, Blasone L et al. Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome. Am I Gastroenterol 2005:100:1516-22.